Stock Research for ACOR

ACOR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ACOR Stock Chart & Research Data

The ACOR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACOR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACOR Due diligence Resources & Stock Charts

The ACOR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACOR Detailed Price Forecast - CNN Money CNN View ACOR Detailed Summary - Google Finance
Yahoo View ACOR Detailed Summary - Yahoo! Finance Zacks View ACOR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ACOR Trends & Analysis - Trade-Ideas Barrons View ACOR Major Holders - Barrons
NASDAQ View ACOR Call Transcripts - NASDAQ Seeking View ACOR Breaking News & Analysis - Seeking Alpha
Spotlight View ACOR Annual Report - CompanySpotlight.com OTC Report View ACOR OTC Short Report - OTCShortReport.com
TradeKing View ACOR Fundamentals - TradeKing Charts View ACOR SEC Filings - Bar Chart
WSJ View Historical Prices for ACOR - The WSJ Morningstar View Performance/Total Return for ACOR - Morningstar
MarketWatch View the Analyst Estimates for ACOR - MarketWatch CNBC View the Earnings History for ACOR - CNBC
StockMarketWatch View the ACOR Earnings - StockMarketWatch MacroAxis View ACOR Buy or Sell Recommendations - MacroAxis
Bullish View the ACOR Bullish Patterns - American Bulls Short Pains View ACOR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ACOR Stock Mentions - StockTwits PennyStocks View ACOR Stock Mentions - PennyStockTweets
Twitter View ACOR Stock Mentions - Twitter Invest Hub View ACOR Investment Forum News - Investor Hub
Yahoo View ACOR Stock Mentions - Yahoo! Message Board Seeking Alpha View ACOR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ACOR - SECform4.com Insider Cow View Insider Transactions for ACOR - Insider Cow
CNBC View ACOR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACOR - OTC Markets
Yahoo View Insider Transactions for ACOR - Yahoo! Finance NASDAQ View Institutional Holdings for ACOR - NASDAQ


Stock Charts

FinViz View ACOR Stock Insight & Charts - FinViz.com StockCharts View ACOR Investment Charts - StockCharts.com
BarChart View ACOR Stock Overview & Charts - BarChart Trading View View ACOR User Generated Charts - Trading View




Latest Financial News for ACOR


Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?
Posted on Friday December 14, 2018

The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed heavily on the minds of investors. Both the S&P 500 and Russell 2000 sank as a result, with the Russell 2000, […]


Here's Why Acorda Therapeutics Shares Sunk 15% Today
Posted on Tuesday December 11, 2018

Wall Street is increasingly concerned about this biotech stock's future.


Acorda Launches Art Initiative to Foster Better Conversations About Parkinson’s Symptoms
Posted on Wednesday December 05, 2018

Acorda Therapeutics, Inc. (ACOR) today launched Framing OFF Through Art℠, a new initiative that uses the power of art to allow people with Parkinson’s to help recognize and articulate their OFF period experiences. Many people with Parkinson’s experience OFF periods in which Parkinson’s symptoms re-emerge even though the person is on an existing treatment regimen. OFF periods affect about 40 percent of the approximately one million people with Parkinson’s in the U.S. The need for better dialogue about OFF period symptoms was originally highlighted in the “Live Well.


Should You Worry About Acorda Therapeutics Inc’s (NASDAQ:ACOR) CEO Pay?
Posted on Tuesday November 27, 2018

Ron Cohen became the CEO of Acorda Therapeutics Inc (NASDAQ:ACOR) in 1995. First, this article will compare CEO compensation with compensation at similar sized companies. Then we’ll look at a


Stock Market & Investing Books

Enter a stock symbol to view the stock details.